The Food and Drug Administration (FDA) is being congratulated on a breakthrough in the conventional belabored FDA approval process. Ben Steele, contributor to Eye for Pharma reported that the pharmas Johnson & Johnson and Vertex Pharmaceuticals spoke out in...
Boston Pharma Staffing
Controlling Cholesterol through R&D
Drug developers are spending billions on R&D and extensive studies on treatments for high cholesterol based on genomic sequencing. According to Damian Garde of Fiercebiotech, Amgen is the current leader and may be the first to launch a new drug; the company is...